Clinical Trial Update: Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intradetrusor abobotulinumtoxinA and incobotulinumtoxinA in women with overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• AbobotulinumtoxinA (abobotulinumtoxinA)
• IncobotulinumtoxinA (incobotulinumtoxinA)

Snippet

Sponsor: Niko Kavcic | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED